Sedana Medical AB - Asset Resilience Ratio
Sedana Medical AB (SEDANA) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Sedana Medical AB debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Sedana Medical AB's Asset Resilience Ratio has changed over time. See Sedana Medical AB (SEDANA) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets Composition Over Time
This chart breaks down Sedana Medical AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Sedana Medical AB assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Sedana Medical AB maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Sedana Medical AB Industry Peers by Asset Resilience Ratio
Compare Sedana Medical AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
SIEMENS HEALTH ADR/050
F:SHL1 |
Medical Devices | 1.05% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Somnomed Ltd
AU:SOM |
Medical Devices | 24.67% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
|
Promimic AB
ST:PRO |
Medical Devices | 8.62% |
Annual Asset Resilience Ratio for Sedana Medical AB (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Sedana Medical AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | Skr0.00 ≈ $0.00 |
Skr1.02 Billion ≈ $109.70 Million |
-- |
| 2023-12-31 | 14.85% | Skr150.62 Million ≈ $16.21 Million |
Skr1.01 Billion ≈ $109.13 Million |
-56.76pp |
| 2021-12-31 | 71.62% | Skr836.18 Million ≈ $89.99 Million |
Skr1.17 Billion ≈ $125.65 Million |
+8.93pp |
| 2020-12-31 | 62.69% | Skr376.17 Million ≈ $40.48 Million |
Skr600.10 Million ≈ $64.58 Million |
-15.62pp |
| 2019-12-31 | 78.31% | Skr464.56 Million ≈ $49.99 Million |
Skr593.25 Million ≈ $63.84 Million |
+9.49pp |
| 2018-12-31 | 68.82% | Skr159.35 Million ≈ $17.15 Million |
Skr231.55 Million ≈ $24.92 Million |
+3.87pp |
| 2017-12-31 | 64.94% | Skr85.32 Million ≈ $9.18 Million |
Skr131.38 Million ≈ $14.14 Million |
+28.72pp |
| 2016-12-31 | 36.22% | Skr8.30 Million ≈ $892.83K |
Skr22.90 Million ≈ $2.46 Million |
-- |
About Sedana Medical AB
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; S… Read more